HOME
Technology
Life
Discover science
Medicine - Health
Event
EntertainmentStop testing Ebola vaccine due to side effects
The clinical trial of an Ebola vaccine in Switzerland was suspended, after four patients complained of joint pain in their legs and arms.
Ebola virus.(Photo: BBC)
The trial was stopped a week earlier than expected, on all 59 volunteers involved, to " prevent risk , " according to representatives of the University Hospital of Geneva. The trial will start over 15 volunteers from January 5, if tests show the symptoms of arthralgia are mild and transient.
The vaccine was tested by NewLink, and has recently been licensed to Merck.
Currently, there are no licensed vaccines for use against Ebola. In addition to the above vaccine, another vaccine (developed by GlaxoSmithKline pharmaceutical company) is also being tested on humans in some countries.
Ebola virus has raged in West Africa for the past few months, and has claimed more than 6,000 lives.
- The United States accelerates testing of Ebola vaccine in humans
- Officially tested the Ebola vaccine on the human body
- The University of Geneva continues to test the Ebola virus vaccine
- Ebola vaccine may be completed in 2017
- Canada will donate the Ebola vaccine to WHO
- The anti-Ebola vaccine is about to be tested on a large scale
- Successfully tested Ebola vaccine
- Ebola vaccine has been 100% effective
- New hope in the fight against Ebola virus
- The first Ebola vaccine was approved for circulation
- Difficult to stop Ebola outbreak if there is no vaccine
- Successful development of antibodies that treat Ebola
Green tea cleans teeth better than mouthwash?
Death kiss: This is why you should not let anyone kiss your baby's lips
What is salmonellosis?
Caution should be exercised when using aloe vera through eating and drinking